Advertisement

Drug-Induced Malabsorption

  • T. Wehrmann
  • B. Lembcke
  • W. F. Caspary

Abstract

Drugs may induce malassimilation of nutrients by direct or indirect, specific or non specific modes of action. It is important to distinguish first between the interference of drugs with the process of digestion or absorption since an increased loss of nutrients in the stool may be caused by a derangement of either or both functions. These side effects may be induced by a variety of chemically totally different compounds and may be independent of the route of drug administration (enteral or paren-tereral), while excretion of drugs (or their metabolites) in gut secretions and bile accounts for the interference with nutrient absorption even after parenteral administration. However, the clinical relevance of the different pathophysiological mechanisms merits careful interpretation. Apart from the clinical importance of adverse drug reactions, the therapeutic potential of inhibiting digestive and absorptive gastrointestinal functions in the treatment of diabetes mellitus (acarbose), hyperlipid-aemia (cholestyramine), and dumping syndrome (guar, so called “gelling agents”) had been established. For the purpose of this review, the effects of drugs on the gastrointestinal absorptive function are structured according to six different underlying pathophysiological mechanisms [88] (Table 1).

Keywords

Bile Acid Gastric Emptying Familial Mediterranean Fever Gastric Inhibitory Polypeptide Breath Hydrogen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Asatoor, AM, Chamberlain, MJ, Emmerson, BT, Johnson, JR, Levi, AJ, Milne, MD (1967) metabolic effects of oral neomycin. Clin Sci 33: 111–124PubMedGoogle Scholar
  2. 2.
    Aubell, R, Boehme, K, Berchtold, P (1983) Blood glucose concentrations and glycosuria during and after one year of acarbose therapy. Arzneimittel Forschung 33: 1314–1318PubMedGoogle Scholar
  3. 3.
    Barrowman, JA, D’Mello, A, Herxheimer, A (1973) A single dose of neomycin impairs absorption of vitamin A (retinol) in man. Europ J Clin Pharmaco 15: 199–201Google Scholar
  4. 4.
    Bartelink, A (1972) Drug induced diseases of the gastrointestinal tract. In: Meyler, L, Peck, HM (eds) Drug-induced diseases, vol. 4. Excerpta Medica, Amsterdam, pp 403–422Google Scholar
  5. 5.
    Baugh, CM, Krumdieck, CL (1969) Effect of phenytoin on folic acid conjugases in man. Lancet ii: 512–521Google Scholar
  6. 6.
    Berchtold, P, Bolli, P, Arbenz, H (1969) Intestinale Absorptionsstörung infolge Metforminbehandlung. Diabetologia 5: 405 (Abstract)PubMedGoogle Scholar
  7. 7.
    Biro, L, Banyasz, T, Kovacs, MB, Bajor, M (1961) Die Wirkung des Phenyläthyl-biguanids auf die Glukoseresorption. Klin Wochenschr 39: 760–762Google Scholar
  8. 8.
    Blackburn, NA, Redfern, JS, Jarjis, H (1984) The mechanism of action of guar gum in improving glucose tolerance in man. Clin Sci 66: 329–336PubMedGoogle Scholar
  9. 9.
    Bloch, R, Menge, H, Schaarschmidt, WD, Müller, M, Creutzfeldt, W (1973) Biochemische, histochemische, histologische und funktionelle Untersuchungen zur Phenforminwirkung auf die Dünndarmschleimhaut bei Ratte und Mensch. Klin Wochenschr 51: 235–241PubMedGoogle Scholar
  10. 10.
    Blundell, JE, Catham, CJ, Moniz, E, Mcarthur, RA, Rogers, PJ (1979) Structural analysis of the actions of amphetamine and fenfluramine on food intake and feeding behaviour in animals and in man. Curr Med Res Opinion 6 (suppl. 1): 34–54Google Scholar
  11. 11.
    Bodemar, G, Norlander, B, Walen, A (1979) Diminished absorption of Cimetidine caused by antacids. Lancet i: 444–445Google Scholar
  12. 12.
    Boivin, M, Flourie, B, Rizz, GA, Go, YLW, DiMagno, EP (1988) Gastrointestinal and metabolic effects of amylase inhibition in diabetics. Gastroenterology 94: 387–391PubMedGoogle Scholar
  13. 13.
    Bo-Linn, GW, Santa Ana, CA, Morawski, SG, Fordtran, JS (1982) Starch Blockers — their effect on calorie absorption from a high-starch meal. N Engl J Med 307: 1413–1416PubMedGoogle Scholar
  14. 14.
    Bond, JH, Levitt, MD (1976) Fate of soluble carbohydrate in the colon of rats and man. J Clin Invest 57: 1158–1164PubMedGoogle Scholar
  15. 15.
    Borgström, B (1969) Quantification of cholesterol absorption in man by fecal analysis after the feeding of a single-isotope labelled meal. J Lipid Res 10: 331–337PubMedGoogle Scholar
  16. 16.
    Capei, ID, Pinnock, MH, Williams, DC (1979) Methotrexate increase passive permeation of the mucosal membrane barrier in the rat. Eur J Clin Oncology Cancer 15: 127–131Google Scholar
  17. 17.
    Caspary, WF (1971) Effect of biguanides on intestinal transport of sugars, amino acids and calcium. Naunyn Schmiederbergs Arch Pharmacol 269: 421–422Google Scholar
  18. 18.
    Caspary, WF (1972) Inhibition of calcium transport by diphenylhydantoin in rat duodenum. Naunyn Schmiedebergs Arch Pharmacol 274: 146–153PubMedGoogle Scholar
  19. 19.
    Caspary, WF (1977) Biguanides and intestinal absorption. Acta Hepato Gastroenterol 24: 473–480Google Scholar
  20. 20.
    Caspary, WF (1985) Diabetes mellitus: Verzögerung der Kohlenhydrat-Resorption als therapeutisches Prinzip. Dtsch Ärzteb 182: 1424–1428Google Scholar
  21. 21.
    Caspary, WF (1990) Interruption of the entero-pancreatic axis: effects of induced malabsorption. Europ J Clin Invest 20 (suppl. 1): 58–64Google Scholar
  22. 22.
    Caspary, WF, Creutzfeldt, W (1971) Analysis of the inhibitory effect of biguanides on glucose absorption. Inhibition of active sugar transport. Diabetolo-gia 7: 379 (abstract)Google Scholar
  23. 23.
    Caspary, WF, Creutzfeldt, W (1972) Hemmung der intestinalen von Zuckern und Aminosäuren durch Prenylamin (Segontin). Dtsch Med Wochenschr 97: 394–396PubMedGoogle Scholar
  24. 24.
    Caspary, WF, Creutzfeldt, W (1973) Inhibition of intestinal amino acid transport by blood sugar lowering biguanides. Diabetologia 9: 6–12PubMedGoogle Scholar
  25. 25.
    Caspary, WF, Creutzfeldt, W (1975) Inhibition of bile salt absorption by blood sugar lowering biguanides. Diabetologia 11: 113–117PubMedGoogle Scholar
  26. 26.
    Caspary, WF, Graf, S (1978) Bindung von Gallensäuren an Antacida. Dtsch Med Wochenschr 103: 825–827PubMedGoogle Scholar
  27. 27.
    Caspary, WF, Kaiisch, H (1979) Effect of α-glucosedehydrolase inhibition on intestinal absorption of sucrose, water and sodium in man. Gut 20: 750–755PubMedGoogle Scholar
  28. 28.
    Caspary, WF, Hesch, RD, Matte, R, Ritter, H, Kattermann, R, Emrich, D (1974) Therapie der Calciumresorptionsstörung unter antiepileptischer Behandlung mit 25-hydroxycholecalciferol (25-OH-CC). Verh Dtsch Ges Inn Med 80: 1277–1280PubMedGoogle Scholar
  29. 29.
    Caspary, WF, Zavada, I, Reimold, V, Graf, S, Creutzfeldt, W (1977) Alteration of bile acid metabolism and vitamin B12 absorption in diabetics on biguanides. Diabetologia 13: 187–193PubMedGoogle Scholar
  30. 30.
    Caspary, WF, Elsenhans, B, Süfke, U, Graf, S, Creutzfeldt, W (1980) Effect of dietary fiber on absorption and motility. Front Hormone Res 7: 202–207Google Scholar
  31. 31.
    Chungi, VS, Bourne, DW, Dittert, LW (1979) Competitive inhibition between folic acid and methotrexate for transport carrier in the rat small intestine. J Phar-maceut Sci 68: 1552–1553Google Scholar
  32. 32.
    Clissold, SP, Edwards, C (1991) Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35: 214–243Google Scholar
  33. 33.
    Cohen, MI, McNamara, H (1970) The effect of colchicine on guinea pig intestinal enzyme activity. Am J Dig Dis 15: 247–250PubMedGoogle Scholar
  34. 34.
    Cooke, N, Teitelbaum, S, Avioli, LV (1978) Antacid-induced osteomalacia and nephrolithiasis. Arch Intern Med 138: 1007–1009PubMedGoogle Scholar
  35. 35.
    Cousar, CD, Gadacz, TR (1981) Comparison of antacids on the binding of bile salts. Gastroenterology 80: 1357–1360Google Scholar
  36. 36.
    Craft, AW, Kay, HEM, Lawson, DN, McElwein, TJ (1977) Methotrexate-induced malabsorption in children with acute lymphoblastic leucaemia. Br Med J II: 1511–1512Google Scholar
  37. 37.
    Creaven, PJ, Mihich, E (1977) The clinical toxicity of anticancer drugs and its prediction. Sem Oncol 4: 147–163Google Scholar
  38. 38.
    Creutzfeldt, W (1982) Proceedings of the first international symposium on acarbose. Excerpta Medica, AmsterdamGoogle Scholar
  39. 39.
    Creutzfeldt, W, Willms, B, Caspary, WF (1971) The mechanism of action of blood glucose lowering biguanides. In: Rodríguez RR, Vallance Owen, J (eds) Diabetes, Excerpta Medica, Amsterdam, p 95Google Scholar
  40. 40.
    Dietschy, JM, Siperstein, MD (1965) Cholesterol synthesis by the gastrointestinal tract: localisation and mechanisms of control. J Clin Invest 44: 1311–1327PubMedGoogle Scholar
  41. 41.
    Dimitriadis, GD, Tessari, P, Go, VLW, Gerich, JE (1985) α-Glucosidase-Hemmung bessert die postprandiale Hyperglykämie und senkt den Insulinbedarf bei insulinpflichtgem Diabetes mellitus. Dtsch Ärzteb 182: 1413–1423Google Scholar
  42. 42.
    Dixon, W, Paulley, F (1962) Anticholinergic agents favours small intestinal overgrowth during long term application. Med J Aust 3: 737–740Google Scholar
  43. 43.
    Dobbins, WO, Herrero, BA, Mansbach, CM (1968) Morphologie alterations associated with neomycin induced malabsorption. Am J Med Sci 63–77Google Scholar
  44. 44.
    Ebert, R, Bornmann, V, Creutzfeldt, W (1990) Wirkungen von Motilin und Erythromycin auf die Magenentleerung und metabolische Antwort nach Gluco-segabe bei Normalpersonen. Z Gastroenterol 29: 448 (abstract)Google Scholar
  45. 45.
    Ecknaer, R (1983) Dünndarmveränderungen unter Zytostatika. In: Caspary, WF (ed) Handbuch der Inneren Medizin, Vol. III/3B Dünndarm, Springer, Berlin Heidelberg New York, pp 571–597Google Scholar
  46. 46.
    Ehrenfeld, M, Levy, M, Sharon, P, Rachmilewitz, D, Eliakim, M (1982) Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever). Dig Dis Sci 27: 723–727PubMedGoogle Scholar
  47. 47.
    Ehrhard-Schmelzer, S, Lembcke, B, Cremer, P, Caspary, WF, Creutzfeldt, W (1983) Kontrollierte Studie über den Effekt von Guar bei ambulanten Typ-II-Diabetikern. In: Huth, K, Bräuning, C (eds) Pflanzenfasern — Neue Wege in der Stoffwechseltherapie. Beiträge zu Infusionstherapie und klinischen Ernährung -Forschung und Praxis, vol. 12. Karger, Basel, pp 195–205Google Scholar
  48. 48.
    Eichler, HG, Korn, A, Gasic, S, Pirson, W, Businger, J (1984) The effect of a new specific α-amylase inhibitor on postprandial glucose and insulin excursions in normal subjects and type 2 (noninsulin-dependent) diabetic patients. Diabe-tologia 26: 278–281Google Scholar
  49. 49.
    Elsenhans, B, Süfke, U, Blume, R, Caspary, WF, (1980) The influence of carbohydrate gelling agents on rat intestinal transport of monosaccharides and neutral amino acids in vitro. Clin Sci 59: 373–380PubMedGoogle Scholar
  50. 50.
    Elsenhans, B, Süfke, U, Blume, R, Caspary, WF (1981) In vitro inhibition of rat intestinal surface hydrolysis of disaccharides and dipeptides by guaran. Digestion 21: 98–103PubMedGoogle Scholar
  51. 51.
    Elsenhans, B (1983) Pharmacology of carbohydrate gelling agents. In: Creutzfeldt, W, Fölsch, UR (eds) Delaying absorption as a therapeutic principle in metabolic diseases. Thieme, Stuttgart, pp 29–43Google Scholar
  52. 52.
    Elsenhans, B, Zenker, R, Caspary, WF (1984) Guaran effect on rat intestinal absorption. A perfusion study. Gastroenterology 86: 645–653PubMedGoogle Scholar
  53. 53.
    Eyssen, H, Evrad, E, Vanderhaege, H (1966) Cholesterol-lowering effects of N-methylated neomycin and basic antibiotics. J Lab Clin Med 68: 753–768PubMedGoogle Scholar
  54. 54.
    Faloon, WW (1970) Metabolic effects of nonabsorbable antibacteria agents. Am J Clin Nutr 23: 645–651PubMedGoogle Scholar
  55. 55.
    Faloon, WW, Woolfolk, D, Nankin, H, Wallace, K, Haro, EN (1964) The role of bile salts in neomycin induced malabsorption. J Clin Invest 43: 1254Google Scholar
  56. 56.
    Faloon, WW, Paes, IC, Wollfolk, D, Nankin, K, Wallace, K, Haro, EN (1966) Effect of neomycin and kanamycin upon intestinal absorption. Ann New York Acad Sci 132: 879–887Google Scholar
  57. 57.
    Faloon, WW, Rublis, A, Race, TF, Webb, DI (1969) Colchicine and cholesterol metabolism. Am J Clin Nutr 22: 671–672Google Scholar
  58. 58.
    Flourie, B, Vidon, N, Florent, CH, Bernier, JJ (1984) Effect of pectin on jejunal glucose absorption and unstirred layer thickness in normal man. Gut 25: 936–941PubMedGoogle Scholar
  59. 59.
    Fölsch, UR, Ebert, R, Creutzfeldt, W (1981) Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. Scand J Gastroenterol 16: 629–632PubMedGoogle Scholar
  60. 60.
    Frizzel, RA, Nellans, HN, Acheson, LS (1973) Effect of cycloheximide on influx across the brush border membrane of rabbit intestine. Biochem Biophys Acta 191:302–307Google Scholar
  61. 61.
    Garty, M, Hurtwitz, A (1980) Effect of Cimetidine and antacids on gastrointestinal absorption of tetracycline. Clin Pharmacol Ther 28: 225–228Google Scholar
  62. 62.
    Gottesbühren, H, Raida, H, Riecken, EO (1974) Untersuchungen zum Einfluß von Prenylamin auf die Dünndarmresorption beim Menschen. Dtsch Med Wochenschr 99: 2104–2105Google Scholar
  63. 63.
    Gross, L, Brotman, M (1970) Hypoprothrombinemia and hemorrhage associated with cholestyramine therapy. Ann Int Med 72: 95–96PubMedGoogle Scholar
  64. 64.
    Gugler, R, Allgayer, H (1990) Effects of antacids on the clinical pharmacokinetics of drugs. CHn Pharmacokinet 3: 210–219Google Scholar
  65. 65.
    Gyr, K, Berger, W, Göschke, H, Stalder, GA (1970) Postprandiale Beschwerden nach Gastrektomie und ihre Beeinflussung durch Dimethylbiguanid. Dtsch Med Wochenschr 95: 2421–2431PubMedGoogle Scholar
  66. 66.
    Hahn, TJ, Hendin, BA, Scharp, CR (1975) Serum 25-hydroxy-cholecalciferol levels and bone mass in children on chronic anticonvulsant therapy. N Engl J Med 292: 550–554Google Scholar
  67. 67.
    Hall, GJL, Davies, AE (1969) Inhibition of iron absorption by magnesium tri-silicate. Med J Aust 10: 95–96Google Scholar
  68. 68.
    Hampton, JC (1966) A comparison of the effects of irradiation and colchicine on the intestinal mucosa of the mouse. Rad Res 28: 37–59Google Scholar
  69. 69.
    Harmuth-Hoene, AE, Schelenz, R (1980) Effect of dietary fiber on mineral absorption in growing rats. J CHn Nutrl 10: 1774–1784Google Scholar
  70. 70.
    Hartwich, G (1974) Side effects of a cytostatic treatment on the gastrointestinal tract. Acta Hepatogastroenterol 21: 89–92Google Scholar
  71. 71.
    Hartwich, G, Domschke, W, Matzkies, F, Pesch, HG (1975) Disaccharidases in rat small intestine mucosa following cytostatic treatment with adriamycin. Res Exp Med 166: 23–34Google Scholar
  72. 72.
    Heaton, KW, Lever, JV, Barnard, D (1972) Osteomalecia associated with cholestyramine therapy for postilectomy diarrhea. Gastroenterology 62: 642–646PubMedGoogle Scholar
  73. 73.
    Herbst, JJ, Hurwitz, R, Sunshine, P, Kretchmer, N (1970) Effects of colchicine on intestinal disaccharidases: corellation with biochemical aspects of cellular renewal. J CHn Invest 49: 530–536Google Scholar
  74. 74.
    Höffken, G, Lode, H, Wiley, R, Glatzel, TD, Slevers, D (1988) Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effect of food and antacid intake. Rec Infect Dis 20: 138–139Google Scholar
  75. 75.
    Holgate, AM, Read, NW (1983) Relationship between small bowel transit time and absorption of a soHd meal. Influence of metoclopramide, magnesium sulfat, and lactulose. Dig Dis Sci 28: 812–819PubMedGoogle Scholar
  76. 76.
    Hollingsworth, DR, Amatruda, TT (1969) Toxic and therapeutic effects of EMTP in obesity. Clin Pharmacol Ther 10: 540–542PubMedGoogle Scholar
  77. 77.
    Houlihan, M, Scott, JM, Boyle, PH, Wier, DB (1972) The effect of phenytoin on the absorption of synthetic foHc acid polyglutamate. Gut 13: 189–190PubMedGoogle Scholar
  78. 78.
    Hvidt, S, Kjeldsen, K (1963) Malabsorption induced by small doses of neomycin sulfate. Acta Med Scand 173: 699 (abstract)PubMedGoogle Scholar
  79. 79.
    Insogna, KL, Bordly, DR, Card, RJ, Lockwood, DA (1980) Osteomalacia and weakness. In: Jacobson, ED, Prior, JT, Faloon, WW (1960) Malabsorptive syndrome induced by neomycin: morphologic alterations in the jejunal mucosa. J Lab Clin Med 56: 245–250Google Scholar
  80. 80.
    Jacobson, ED, Chodos, RB, Faloon, WW (1960) An experimental malabsorption syndrome induced by neomycin. Am J Med 28: 524–533PubMedGoogle Scholar
  81. 81.
    Janssens, J, Peeters, TL, Vantrappen, G, Tack, J, Urbain, JL, DeRoo, M, Muls, E, Boullion, R (1990) Improvement of gastric emptying in diabetic gastropare-sis by erythromycin: preliminary studies. N Engl J Med 322: 1028–1030PubMedGoogle Scholar
  82. 82.
    Jenkins, DJA, Leeds, AR, Slavin, B, Mann, J, Jepson, EM (1979) Dietary fiber and blood lipids: reduction of serum cholesterol in type II hyperlipidemia by guar gum. Am J Clin Nutr 32: 16–18PubMedGoogle Scholar
  83. 83.
    Jenkins, DJA, Hill, MS, Cummings, JH (1975) Effect of wheat fiber on blood lipids, fecal steroid excretion and serum iron. Am J Clin Nutr 28: 1408–1411PubMedGoogle Scholar
  84. 84.
    Layer, P, Carlson, GL, DiMagno, EP (1985) Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humanes. Gastroenterology 88: 1895–1902PubMedGoogle Scholar
  85. 85.
    Lembcke, B, Caspary, WF (1977) Dipeptid-Transport-Beeinflussung durch Phenformin. Z Gastroenterol 15: [suppl] 36–38Google Scholar
  86. 86.
    Lembcke, B (1987) Beeinflussung der Resorption — Resorptionsverzögerung als therapeutisches Prinzip. In: Caspary, WF (ed) Diabetes Forum I: Struktur und Funktion des Dünndarmes — Therapie des Diabetes mellitus. Excerpta Medica, Amsterdam, pp 269–287Google Scholar
  87. 87.
    Lembcke, B, Caspary, WF (1983) Atemanalytische Funktionstests. In: Caspary, WF (ed) Handbuch der Inneren Medizin, vol. III/3 A Dünndarm, Springer, Berlin, Heidelberg, New York, pp 488–520Google Scholar
  88. 88.
    Lembcke, B, Caspary, WF (1988) Malabsorption syndromes. Clin Gastroenterol: 329–351Google Scholar
  89. 89.
    Lembcke, B, Creutzfeldt, W, Schleser, S, Ebert, R, Shaw, C, Koop, I (1987) Effect of somatostatin analogue sandostatin (SMS 201–995) on gastrointestinal, pancreatic and biliary function and hormone release in normal man. Digestion 36: 108–124PubMedGoogle Scholar
  90. 90.
    Lembcke, B, Diederich, M, Fölsch, UR, Creutzfeldt (1990) Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the α-glucosidase inhibitor miglitol. Digestion 47: 47–55PubMedGoogle Scholar
  91. 91.
    Lembcke, B, Fuchs, C, Hesch, RD, Caspary, WF (1982) Effect of long term antacid administration on mineral metabolism. In: Halter, F (ed) Antacids in the eighties, Urban Schwarzenberg, Munich, pp 112–122Google Scholar
  92. 92.
    Leveille, GA, Powel, RC, Sauberlich, HE, Nunes, WT (1963) Effect of orally and parenterally administered neomycin on plasma lipids in normal subjects. Am J Clin Nutr 12: 421–426PubMedGoogle Scholar
  93. 93.
    Levin, RJ (1968) Anatomical and functional changes on the small intestine induced by 5-fluorouracil. J Physiol 197: 73–74Google Scholar
  94. 94.
    Lotz, M, Zisman, E, Bartter, FC (1968) Evidence of a phosphorus depletion syndrome in man. N Engl J Med 278: 409–415PubMedGoogle Scholar
  95. 95.
    MacKenzie, IJ, Donaldson, RM (1972) Effect of divalent kations and pH on intrinsic factor-mediated attachment of vitamin B12 to intestinal microvillous membranes. J Clin Invest 51: 2465–2471PubMedGoogle Scholar
  96. 96.
    Mantylä, R, Männisto, PT, Vuorela, A, Sunderberg, S, Ottoila, P (1984) Impairment of Captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol 33: 626–629Google Scholar
  97. 97.
    Maxwell, JD, Hunter, J, Stewart, DA, Ardeman, S, Williams, R (1972) Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction? Br Med J 1: 297–299PubMedGoogle Scholar
  98. 98.
    Meyer, BH, Müller, FO, Clur, BK, Grigoleit, HG (1983) Effects of tendamistate (α-amylase inactivator) on starch metabolism. Br J Clin Pharmacol 16: 145–148PubMedGoogle Scholar
  99. 99.
    Mizuno, M, Hamaura, T, Hashida, M, Sezaki, H (1986) Changes in D-glucose uptake by brush border vesicles from small intestine of rats treated with mitomycin C. Biochem Pharmacol 35: 1153–1158PubMedGoogle Scholar
  100. 100.
    Olsen, WA, Rasmussen, HK (1974) Effect of phenformin on carbohydrate absorption in man. Diabetes 23: 716–718PubMedGoogle Scholar
  101. 101.
    Paes, IC, Searl, B, Rubert, MW, Faloon, WW (1967) Intestinal lactase deficiency and saccharidase malabsorption during oral neomycin administration. Gastroenterology 53: 49–58PubMedGoogle Scholar
  102. 102.
    Palva, IP, Salokannel, SJ, Timonen, T, Myränen, J (1972) Malabsorption and deficiency of vitamin B12 during treatment with slow-release potassium chloride. Acta Med Scand 191: 355–357PubMedGoogle Scholar
  103. 103.
    Pinkerton, CR, Milla, JP (1984) Methotrexate enterotoxicity: Influence of drug dose and timing in the rat. Br J Cancer 49: 97–101PubMedGoogle Scholar
  104. 104.
    Ponz de Leon, M, Iori, R, Barbolini, G, Pompei, G, Zaniol, P, Carulli, N (1982) Influence of small bowel transit time on dietary cholesterol absorption in human beings. N Engl J Med 307: 102–103PubMedGoogle Scholar
  105. 105.
    Puls, W, Krause, HP, Müller, L, Schutt, H, Sitt, R, Thomas, G (1984) Inhibitors on the rate of carbohydrate and lipid absorption by the intestine. Int J Obesity 8: (suppl. 1) 181–190Google Scholar
  106. 106.
    Race, TF, Paes, IC, Faloon, WW (1970) Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and carthartic agents. Am J Med Sci 259: 32–41PubMedGoogle Scholar
  107. 107.
    Reinhold, JG, Nasr, K, Lahimgarzadeh, A, Hedayatti, H (1973) Effects of purified phytate and phytate rich bread upon metabolism of zinc, calcium, phosphorus and nitrogen in man. Lancet I: 283–288Google Scholar
  108. 108.
    Reisenauer, AM, Halsted, CH (1981) Human jejunal brush border folate conju-gase. Characteristics and inhibition by salicylasulfapyridine. Biochim Biophys Acta 659: 62–69PubMedGoogle Scholar
  109. 109.
    Riecken, EO, Rosenbaum, R, Bloch, R, Creutzfeldt, W (1969) Tierexperimentelle Untersuchungen zur Frage der Spezifität der Dünndarmschleimhautverän-derungen bei der einheimischen Sprue. Klin Wochenschr 47: 202–214PubMedGoogle Scholar
  110. 110.
    Robinson, JWL (1972) Experimental intestinal malabsorption states and their relation to clinical syndromes. Klin Wochenschr 50: 173–185PubMedGoogle Scholar
  111. 111.
    Robinson, JWL, Antoniolo, JA, Vannotti, A (1966) The effect of oral methotrexate on the rat intestine. Biochem Pharmacol 15: 1479–1489PubMedGoogle Scholar
  112. 112.
    Roche, AC, Bognel, JCL, Bognel, C, Bernier, JJ (1970) Correlation between the histological changes and glucose intestinal absorption following a single dose of 5-fluorouracil. Digestion 3: 195–212PubMedGoogle Scholar
  113. 113.
    Rosenberg, IH (1981) Intestinal absorption of folate. In: Johnson, LR, Christensen, J, Grossman, MI, Jacobson, ED, Schultz, SG (eds) Physiology of the gastrointestinal tract, vol. 2. Raven, New York, pp 1221–1230Google Scholar
  114. 114.
    Rosenberg, IH, Godwin, HA, Streiff, RR, Castle, WB (1968) Impairment of intestinal deconjugation of dietary folate: a possible explanation of megaloblastic anemia associated with phenytoin therapy. Lancet II: 530–532Google Scholar
  115. 115.
    Rublis, A, Rubert, M, Faloon, WW (1970) Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine. Am J Clin Nutr 28: 1251–1259Google Scholar
  116. 116.
    Sarna, SK, Soergel, KH, Koch, TR, Stone, JE, Wood, CM, Ryan, RP, Arndorfer, RC, Cavanaugh, JH, Nellans, HN, Lee, MB (1991) Gastrointestinal motor effects of erythromycin in humans. Gastroenterology 101: 1488–1496PubMedGoogle Scholar
  117. 117.
    Samuel, P, Salchi, OB, Holtzman, CM (1964) Reduction of serum cholesterol concentrations by paromomycin in patients with atherosclerosis. Proc Soc Exp Biol Med 115: 718–721PubMedGoogle Scholar
  118. 118.
    Sedahagat, A, Samuel, P, Crouse, JR, Ahrens, EH (1975) Effect of neomycin on absorption, synthesis, and/or flux of cholesterol in man. J Clin Invest 55: 12–21Google Scholar
  119. 119.
    Shelly, DW, Doering, PL, Russel, WL, Guild, RT, López, LM (1986) Effect of concomitant antacid administration on plasma Cimetidine concentrations during repetitive dosing. Drug Intell Clin Pharm 20: 792–795PubMedGoogle Scholar
  120. 120.
    Shields, HM (1978) Rapid fall of serum phosphorus secondary to antacid therapy. Gastroenterology 75: 1137–1141PubMedGoogle Scholar
  121. 121.
    Spencer, H, Lender, M (1979) Adverse effects of aluminium-containing antacids on mineral metabolism. Gastroenterology 76: 603–606PubMedGoogle Scholar
  122. 122.
    Steinberg, WM, Lewis, JH, Katz, DM (1982) Antacids inhibit absorption of Cimetidine. N Engl J Med 307: 400–404PubMedGoogle Scholar
  123. 123.
    Steiner, A, Howard, E, Akgun, S (1961) Effect of antibiotics on the serum cholesterol concentration of patients with atherosclerosis. Circulation 24: 729–735PubMedGoogle Scholar
  124. 124.
    Stemmerman, GN, Hayashi, T (1971) Colchicine intoxication: a reappraisal of its pathology based on a study of three fatal cases. Hum Pathol 2: 321–328Google Scholar
  125. 125.
    Szatloczky, E (1971) Behandlung des Dumping-Syndromes mit zuckerresorp-tionshemmenden Mitteln. Dtsch Med Wochenschr 96: 308–311PubMedGoogle Scholar
  126. 126.
    Thomas, FB, Salsburey, D, Greenberger, NJ (1972) Inhibition of iron absorption by cholestyramine: demonstration of diminished iron stores following prolonged administration. Am J Dig Dis Sci 17: 263–269Google Scholar
  127. 127.
    Thompson, GR, Barrowman, J, Gutiérrez, L, Dowling, H (1971) Action of neomycin on the intraluminal phase of lipid absorption. J Clin Invest 50: 319–323PubMedGoogle Scholar
  128. 128.
    Tomkin, GH (1973) Malabsorption of vitamin B12 in diabetic patients treated with phenformin. A comparison with metformin. Br Med J 3: 673–675PubMedGoogle Scholar
  129. 129.
    Trier, JS (1962) Morphologic alterations induced by methotraxate in the mucosa of human proximal intestine. I. Serial observations by light microscopy. Gastroenterology 42: 295–309PubMedGoogle Scholar
  130. 130.
    Trier, JS (1962) Morphologic alterations induced by methotrexate in the mucosa of human proximal intestine. II. Electron microscopy observations. Gastroenterology 43: 407–423PubMedGoogle Scholar
  131. 131.
    Vince, A, Killingley, M, Wrong, OM (1978) Effect of lactulose on ammonia production in a fecal incubation system. Gastroenterology 74: 544–549PubMedGoogle Scholar
  132. 132.
    West, JR, Lloyd, JK (1975) The effect of cholestyramine on intestinal absorption. GUT 16: 93–98PubMedGoogle Scholar
  133. 133.
    Zimmerman, JR, Selhub, J, Rosenberg, IH (1985) Drug-folate interactions in intestinal folate absorption: comparison of sulfasalazine, phenytoin, and salicylates. Gastroenterology 88: 1643–1646Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • T. Wehrmann
    • 1
  • B. Lembcke
    • 1
  • W. F. Caspary
    • 1
  1. 1.Abteilung für Gastroenterologie, Fakultät für Klinische MedizinUniversität HeidelbergMannheimGermany

Personalised recommendations